Answer
Jemperli (dostarlimab) is contraindicated in patients with hypersensitivity to dostarlimab or any of the excipients listed in section 6.1.
Sources for this answer
- JEMPERLI 500 mg concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 17Document updated
Sources checked